Device Trial Radar · NCT04703738
Evaluation of Geistlich Fibro-Gide® in Comparison to CTG for the Treatment Around Implants
Last checked: Nov 20, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Aug 13, 2018
Primary completion
Jun 21, 2021
Study completion May 12, 2026
Sponsor
- Lead sponsor
- Geistlich Pharma AGNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Medelis Inc.
- First posted
- Jan 11, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This double blind, randomized, parallel study evaluates the non-inferiority of Geistlich Fibro-Gide® in comparison to connective tissue graft for soft tissue volume augmentation around dental implants
Conditions
- Soft Tissue Defect
Interventions
Soft tissue flap + Connective Tissue GraftProcedure
The treatment site is accessed using a full thickness flap extending at least 1 full tooth mesial and distal, vertical releasing incisions may be used to obtain flap release for full coverage of the treatment site and graft without compression. The harvest graft donor area will be the palate in the bicuspid region on the same side as the control soft tissue augmentation therapy. The CTG will be harvested using full thickness incisions that include the periosteum and will be closed using suture and coating the incision line with a tissue adhesive. No covering stents or packs should be employed. The CTG will be sling sutured in place and the flap secured using a double sling suturing technique.
Soft tissue flap + Geistlich Fibro-Gide®Device
The treatment site is accessed using a full thickness flap extending at least 1 full tooth mesial and distal, vertical releasing incisions may be used to obtain flap release for full coverage of the treatment site and matrix without compression. Geistlich Fibro-Gide® is cut to shape to the treatment site and placed dry into the site. The flap is secured using a double sling suturing technique.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in gingival soft tissue volume assessed with 3D scanningTime frame: 6 months post treatment
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Regenerative Solutions
Fullerton, California
McClain Schallhorn Periodonitcs
Aurora, Colorado
Perio Health Professionals
Houston, Texas
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.